These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 17458248)

  • 1. [Postprandial hyperglycemia].
    Kawamori R
    Nihon Rinsho; 2006 Dec; 64 Suppl 9():370-7. PubMed ID: 17458248
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of postprandial hyperglycemia by acarbose is a promising therapeutic strategy for the treatment of patients with the metabolic syndrome.
    Yamagishi S; Nakamura K; Takeuchi M
    Med Hypotheses; 2005; 65(1):152-4. PubMed ID: 15893133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical significance of blood glucose levels in the pathogenesis of (atherosclerotic) macroangiopathy].
    Simon K
    Orv Hetil; 2004 Apr; 145(16):861-6. PubMed ID: 15156691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Role of high blood pressure in progression of atherosclerosis in the metabolic syndrome].
    Rakugi H; Ogihara T
    Nihon Rinsho; 2006 Dec; 64 Suppl 9():364-9. PubMed ID: 17458247
    [No Abstract]   [Full Text] [Related]  

  • 5. Metabolic syndrome and insulin resistance: perioperative considerations.
    Bagry HS; Raghavendran S; Carli F
    Anesthesiology; 2008 Mar; 108(3):506-23. PubMed ID: 18292688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of hyperglycemia and insulin with diabetic cardiovascular complications.
    Khamaisi M; Wainstein J; Hancu N; Milicevic Z; Raz I
    Isr Med Assoc J; 2003 Feb; 5(2):116-9. PubMed ID: 12674662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The misconstrued metabolic syndrome essential hypertension. Chronology of interdisciplinary change in attitude].
    Rett K; Wicklmayr M; Dietze G; Mehnert H
    Med Klin (Munich); 1991 Feb; 86(2):86-91. PubMed ID: 2030665
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of type 2 (non-insulin dependent) diabetes and the metabolic syndrome with diet].
    Bruns W
    Z Gesamte Inn Med; 1991 Oct; 46(15):563-7. PubMed ID: 1771927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathophysiology of prediabetes.
    Bhansali A; Dutta P
    J Indian Med Assoc; 2005 Nov; 103(11):594-5, 599. PubMed ID: 16570762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin resistance and metabolic syndrome in patients with nonfunctioning adrenal incidentalomas: a cause-effect relationship?
    Peppa M; Boutati E; Koliaki C; Papaefstathiou N; Garoflos E; Economopoulos T; Hadjidakis D; Raptis SA
    Metabolism; 2010 Oct; 59(10):1435-41. PubMed ID: 20153874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polycystic ovary syndrome and the metabolic syndrome.
    Weerakiet S
    J Med Assoc Thai; 2004 Oct; 87 Suppl 3():S189-93. PubMed ID: 21213522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between pre-operative metabolic syndrome and persistent blood glucose elevation during cardiac surgery in non-diabetic patients.
    Donatelli F; Cavagna P; Di Dedda G; Catenacci A; Di Nicola M; Lorini L; Fumagalli R; Carli F
    Acta Anaesthesiol Scand; 2008 Sep; 52(8):1103-10. PubMed ID: 18840111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in insulin sensitivity in morbidly obese patients with or without metabolic syndrome after gastric bypass.
    Coppini LZ; Bertevello PL; Gama-Rodrigues J; Waitzberg DL
    Obes Surg; 2006 Nov; 16(11):1520-5. PubMed ID: 17132419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human serum metabonomic analysis reveals progression axes for glucose intolerance and insulin resistance statuses.
    Zhang X; Wang Y; Hao F; Zhou X; Han X; Tang H; Ji L
    J Proteome Res; 2009 Nov; 8(11):5188-95. PubMed ID: 19697961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Lipid metabolism and insulin resistance--clinical aspects and pathobiochemistry].
    Gries FA; Hübinger A
    Wien Klin Wochenschr; 1994; 106(24):763-7. PubMed ID: 7846895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Postprandial blood glucose as the driving force in pathogenesis of type 2 diabetes].
    Liebl A
    Med Klin (Munich); 2003 Oct; 98 Suppl 1():7-11. PubMed ID: 14694835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is insulin resistance the cause of the metabolic syndrome?
    Ferrannini E
    Ann Med; 2006; 38(1):42-51. PubMed ID: 16448988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discordance between insulin resistance and metabolic syndrome: features and associated cardiovascular risk in adults with normal glucose regulation.
    Onat A; Hergenç G; Türkmen S; Yazici M; Sari I; Can G
    Metabolism; 2006 Apr; 55(4):445-52. PubMed ID: 16546474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-resistance (IR) in older age.
    Motta M; Bennati E; Ferlito L; Passamonte M; Malaguarnera M
    Arch Gerontol Geriatr; 2008; 46(2):203-9. PubMed ID: 17544523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hereditary postprandial hypertriglyceridemic rabbit exhibits insulin resistance and central obesity: a novel model of metabolic syndrome.
    Kawai T; Ito T; Ohwada K; Mera Y; Matsushita M; Tomoike H
    Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2752-7. PubMed ID: 16990556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.